Clinical Trial Update: An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating the efficacy and safety of tegaserod 6 mg twice daily taken orally in Chinese patients with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Tegaserod (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Constipation | Phase 3 | Status: COMPLETED